You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 10, October 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  Medical News
 This Article
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reporting Methods Compared for Endolymphatic Sac Surgery in Meniere's Disease

WILLIAM L. MEYERHOFF, MD, PHD
Dallas

Arch Otolaryngol Head Neck Surg. 1987;113(10):1046.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

At the 1987 April meeting of the American Otological Society in Denver, Edwin M. Monsell, MD, and Richard J. Wyatt, MD, of the Chicago Otology Group presented their experience with endolymphatic sac surgery for classic Meniere's disease and compared the reporting methods of the American Academy of Ophthalmology and Otolaryngology (1972) with those of the American Academy of Otolaryngology–Head and Neck Surgery (1985). The study included data from 64 patients at least two years following either Silastic implant, valve implant, capillary implant, or decompression. The authors concluded that, although there are many problems inherent in retrospective studies, the 1985 method of evaluating patients represents a significant improvement over the 1972 method because it standardizes the assessment of results for vertigo and specifies the index interval. The authors also feel that endolymphatic sac surgery is still efficacious for the treatment of Meniere's disease, citing its low risk, cost effectiveness, and . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.